The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell ResolutionOrit Rozenblatt–Rosen, Kristen Anton, Aviv Regev et al.|Cell|2020Cited by 602
MITI minimum information guidelines for highly multiplexed tissue imagesDenis Schapiro, Alyce A. Chen, Clarence Yapp et al.|Nature Methods|2022Cited by 86
A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III <i>PIK3CA</i> -Mutant ER-Positive and HER2-Negative Breast CancerX. Cynthia, Matthew J. Ellis, Michael Naughton et al.|Clinical Cancer Research|2017Cited by 74